MedPath

NEUPOGEN

These highlights do not include all the information needed to use NEUPOGEN safely and effectively. See full prescribing information for NEUPOGEN. NEUPOGEN (filgrastim) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1991

Approved
Approval ID

97cc73cc-b5b7-458a-a933-77b00523e193

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 18, 2023

Manufacturers
FDA

Amgen, Inc

DUNS: 039976196

FDA

Amgen Inc

DUNS: 039976196

Products 4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Filgrastim

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55513-209
Application NumberBLA103353
Product Classification
M
Marketing Category
C73585
G
Generic Name
Filgrastim
Product Specifications
Route of AdministrationINTRAVENOUS, SUBCUTANEOUS
Effective DateApril 18, 2023
FDA Product Classification

INGREDIENTS (6)

ACETIC ACIDInactive
Quantity: 0.47 mg in 0.8 mL
Code: Q40Q9N063P
Classification: IACT
FILGRASTIMActive
Quantity: 480 ug in 0.8 mL
Code: PVI5M0M1GW
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SORBITOLInactive
Quantity: 40 mg in 0.8 mL
Code: 506T60A25R
Classification: IACT
POLYSORBATE 80Inactive
Quantity: 0.03 mg in 0.8 mL
Code: 6OZP39ZG8H
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

Filgrastim

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55513-530
Application NumberBLA103353
Product Classification
M
Marketing Category
C73585
G
Generic Name
Filgrastim
Product Specifications
Route of AdministrationINTRAVENOUS, SUBCUTANEOUS
Effective DateApril 18, 2023
FDA Product Classification

INGREDIENTS (6)

FILGRASTIMActive
Quantity: 300 ug in 1 mL
Code: PVI5M0M1GW
Classification: ACTIB
ACETIC ACIDInactive
Quantity: 0.59 mg in 1 mL
Code: Q40Q9N063P
Classification: IACT
SORBITOLInactive
Quantity: 50 mg in 1 mL
Code: 506T60A25R
Classification: IACT
POLYSORBATE 80Inactive
Quantity: 0.04 mg in 1 mL
Code: 6OZP39ZG8H
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

Filgrastim

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55513-924
Application NumberBLA103353
Product Classification
M
Marketing Category
C73585
G
Generic Name
Filgrastim
Product Specifications
Route of AdministrationINTRAVENOUS, SUBCUTANEOUS
Effective DateApril 18, 2023
FDA Product Classification

INGREDIENTS (6)

FILGRASTIMActive
Quantity: 300 ug in 0.5 mL
Code: PVI5M0M1GW
Classification: ACTIB
ACETIC ACIDInactive
Quantity: 0.29 mg in 0.5 mL
Code: Q40Q9N063P
Classification: IACT
SORBITOLInactive
Quantity: 25 mg in 0.5 mL
Code: 506T60A25R
Classification: IACT
POLYSORBATE 80Inactive
Quantity: 0.02 mg in 0.5 mL
Code: 6OZP39ZG8H
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

Filgrastim

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55513-546
Application NumberBLA103353
Product Classification
M
Marketing Category
C73585
G
Generic Name
Filgrastim
Product Specifications
Route of AdministrationINTRAVENOUS, SUBCUTANEOUS
Effective DateApril 18, 2023
FDA Product Classification

INGREDIENTS (6)

FILGRASTIMActive
Quantity: 480 ug in 1.6 mL
Code: PVI5M0M1GW
Classification: ACTIB
ACETIC ACIDInactive
Quantity: 0.94 mg in 1.6 mL
Code: Q40Q9N063P
Classification: IACT
SORBITOLInactive
Quantity: 80 mg in 1.6 mL
Code: 506T60A25R
Classification: IACT
POLYSORBATE 80Inactive
Quantity: 0.06 mg in 1.6 mL
Code: 6OZP39ZG8H
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

Drug Labeling Information

SPL PATIENT PACKAGE INSERT SECTION

LOINC: 42230-3Updated: 4/18/2025

Patient Information
NEUPOGEN® (nu-po-jen)
(filgrastim)
injection

This Patient Information has been approved by the U.S. Food and Drug Administration.

Revised: 01/2021

What is NEUPOGEN?
NEUPOGEN is a man-made form of granulocyte colony-stimulating factor (G-CSF). G-CSF is a substance produced by the body. It stimulates the growth of neutrophils, a type of white blood cell important in the body's fight against infection.
Acute Radiation Syndrome: The effectiveness of NEUPOGEN for this use was only studied in animals, because it could not be studied in people.

Do not take NEUPOGEN if you have had a serious allergic reaction to human G-CSFs such as filgrastim or pegfilgrastim products.

Before you take NEUPOGEN, tell yourhealthcare providerabout all of your medical conditions, including if you:

  • have a sickle cell disorder.

  • have kidney problems.

  • are receiving radiation therapy.

  • are allergic to latex. The needle cap on the prefilled syringe contains dry natural rubber (derived from latex). You should not give NEUPOGEN using the prefilled syringe if you have latex allergies. Ask your healthcare provider about using the vial if you have latex allergies.

  • are pregnant or plan to become pregnant. It is not known if NEUPOGEN will harm your unborn baby.

  • are breastfeeding or plan to breastfeed. It is not known if NEUPOGEN passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive NEUPOGEN?

*NEUPOGEN injections can be given by a healthcare provider by intravenous (IV) infusion or under your skin (subcutaneous injection). Your healthcare provider may decide subcutaneous injections can be given at home by you or your caregiver. If NEUPOGEN is given at home, see the detailed "Instructions for Use" that comes with your NEUPOGEN for information on how to prepare and inject a dose of NEUPOGEN.

  • You and your caregiver should be shown how to prepare and inject NEUPOGEN before you use it, by your healthcare provider.

  • Your healthcare provider will tell you how much NEUPOGEN to inject and when to inject it. Do not change your dose or stop NEUPOGEN unless your healthcare provider tells you to.

  • If you are receiving NEUPOGEN because you are also receiving chemotherapy, your dose of NEUPOGEN should be injectedat least 24 hours before or24 hours after your dose of chemotherapy. Your healthcare provider will do blood tests to monitor your white blood cell count, and if necessary, adjust your NEUPOGEN dose.

  • If you are receiving NEUPOGEN because you have been suddenly (acutely) exposed to an amount of radiation that can affect your bone marrow (Acute Radiation Syndrome), you will need to have blood tests about every 3 days during treatment with NEUPOGEN to check your white blood cell count.

  • If you miss a dose of NEUPOGEN, talk to your healthcare provider about when you should give your next dose.

What are the possible side effects of NEUPOGEN?
NEUPOGEN may cause serious side effects, including:

***Spleen rupture.**Your spleen may become enlarged and can rupture. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach (abdomen) area or your left shoulder.

*A serious lung problem called acute respiratory distress syndrome (ARDS). Call your healthcare provider or get emergency medical help right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing.

*Serious allergic reactions. NEUPOGEN can cause serious allergic reactions. These reactions can cause a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, and sweating. If you have any of these symptoms, stop using NEUPOGEN and call your healthcare provider or get emergency medical help right away.

***Sickle cell crises.**You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive NEUPOGEN. Call your healthcare provider right away if you have symptoms of sickle cell crisis such as pain or difficulty breathing.

*Kidney injury (glomerulonephritis). NEUPOGEN can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms: * swelling of your face or ankles * blood in your urine or dark colored urine * you urinate less than usual *Capillary leak syndrome. NEUPOGEN can cause fluid to leak from blood vessels into your body's tissues. This condition is called "Capillary Leak Syndrome" (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms: * swelling or puffiness and are urinating less than usual * trouble breathing * swelling of your stomach area (abdomen) and feeling of fullness * dizziness or feeling faint * a general feeling of tiredness *Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). * Neupogen may increase the risk of developing a precancerous condition called MDS or a type of blood cancer called AML in people who were born with low white blood cell counts (congenital neutropenia). * If you have breast cancer or lung cancer, when NEUPOGEN is used with chemotherapy and radiation therapy, or with radiation therapy only, you may have an increased risk of developing MDS or AML. * Symptoms of MDS and AML may include tiredness, fever, and easy bruising or bleeding. * Call your healthcare provider if you develop any of these symptoms during treatment with NEUPOGEN. *Decreased platelet count (thrombocytopenia). Your healthcare provider will check your blood during treatment with NEUPOGEN. Tell your healthcare provider if you have unusual bleeding or bruising during treatment with NEUPOGEN. This could be a sign of decreased platelet counts, which may reduce the ability of your blood to clot.

*Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood during treatment with NEUPOGEN.

*Inflammation of your blood vessels (cutaneous vasculitis). Tell your healthcare provider right away if you develop purple spots or redness of your skin.

*Inflammation of the aorta (aortitis). Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported in patients who received NEUPOGEN. Symptoms may include fever, abdominal pain, feeling tired, and back pain. Call your healthcare provider if you experience these symptoms.

The most common side effects experienced in patients receiving NEUPOGEN include:

  • Patients with cancer receiving chemotherapy: fever, pain, rash, cough, and shortness of breath

  • Patients with acute myeloid leukemia receiving chemotherapy: pain, nose bleed, and rash

  • Patients with cancer receiving chemotherapy followed by bone marrow transplant: rash

  • Patients who are having their own blood cells collected: bone pain, fever, and headache

  • Patients with severe chronic neutropenia: pain, decreased red blood cells, nose bleed, diarrhea, reduced sensation, and hair loss

These are not all the possible side effects of NEUPOGEN. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store NEUPOGEN?

  • Store NEUPOGEN in the refrigerator between 36°F to 46°F (2°C to 8°C).

*Do not freeze.

  • Keep NEUPOGEN in the original carton to protect from light or physical damage. Do not leave NEUPOGEN in direct sunlight.

  • Do not shake NEUPOGEN.

  • Take NEUPOGEN out of the refrigerator 30 minutes before use and allow it to reach room temperature before preparing an injection.

  • Throw away (dispose of) any NEUPOGEN that has been left at room temperature for longer than 24 hours.

  • After you inject your dose, throw away (dispose of) any unused NEUPOGEN left in the vials or prefilled syringes.Do not save unused NEUPOGEN in the vials or prefilled syringes for later use.

Keep NEUPOGEN out of the reach of children.

General information about the safe and effective use of NEUPOGEN.
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use NEUPOGEN for a condition for which it was not prescribed. Do not give NEUPOGEN to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about NEUPOGEN that is written for healthcare professionals.

What are the ingredients in NEUPOGEN?
Active ingredient: filgrastim
Inactive ingredients: acetate, polysorbate 80, sodium, sorbitol, and water for Injection
Manufactured by:
Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 U.S.A.
US License No. 1080
Patent: http://pat.amgen.com/neupogen/
© 1991-2021 Amgen Inc. All rights reserved.
1xxxxxx v17

INSTRUCTIONS FOR USE SECTION

LOINC: 59845-8Updated: 4/18/2025

Instructions for Use

NEUPOGEN**®**** (nu-po-jen)**
** (filgrastim)**
** Injection**
Single-Dose Vial

Important

Read the Patient Information for important information you need to know about NEUPOGEN before using these Instructions for Use.

Before you use a NEUPOGEN vial, read this important information:

Storing your NEUPOGEN vial

  • Store the vial in the refrigerator between 36°F to 46°F (2°C to 8°C). *Do not freeze.
  • Keep the vial in the original carton to protect from light or physical damage.
  • Take the vial out of the refrigerator 30 minutes before use and allow it to reach room temperature before preparing an injection.
  • Throw away (dispose of) any vial that has been left at room temperature for longer than 24 hours.
  • After you inject your dose, throw away (dispose of) any unused NEUPOGEN left in the vial.Do not save unused NEUPOGEN in the vial for later use.
  • Keep the NEUPOGEN vial out of the reach of children.

Using your vial

*It is important that you do not try to give the injection unless you or your caregiver has received training from your healthcare provider.

  • Make sure the name NEUPOGEN appears on the carton and vial label. *Only use the vial 1 time. Discard (throw away) the vial with any remaining NEUPOGEN liquid. *Do not use a vial after the expiration date on the label. *Do not shake the vial. *Do notuse the vial if the medicine is cloudy or discolored or contains flakes or particles.

Call your healthcare provider if you have any questions.

Step 1: Prepare

A Remove the vial from the refrigerator.

On a clean, well-lit surface, place the vial at room temperature for30 minutes before you give an injection.

*Do not try to warm the vial by using a heat source such as hot water or microwave. *Do notleave the vial in direct sunlight. *Do not shake the vial.

  • Use the vial only 1 time.

B Inspect the vial.

Make sure the medicine in the vial is clear and colorless.

*Do not use the vial if: * The medicine is cloudy or discolored or contains flakes or particles. * The expiration date printed on the label has passed.

  • In all cases, use a new vial and call your healthcare provider.

C Gather all materials needed for your injection.

Wash your hands thoroughly with soap and water.

On a clean, well-lit work surface, place the:

  • Vial
  • Disposable syringe and needle
  • 2 alcohol wipes
  • Cotton ball or gauze pad
  • Adhesive bandage
  • Sharps disposal container

Image

*Only use the disposable syringes and needles that your healthcare provider prescribes. *Only use the syringes and needles 1 time. Discard (throw away) any used syringes and needles.

  • You should only use a syringe that is marked in tenths of milliliters (mL).
  • Your healthcare provider will show you how to measure the correct dose of NEUPOGEN. This dose will be measured in milliliters (mL).

Step 2: Get Ready

D

Take the cap off the vial. Clean the rubber stopper with one alcohol wipe.

Image

Image

E

Check the carton containing the syringe. If the carton has been opened or damaged, do not use that syringe. Dispose of (throw away) that syringe in the sharps disposal container.

F

Hold the syringe by the barrel with the needle cap pointing up. Carefully pull the needle cap straight off and away from your body.

Image

Image

Pull back on the plunger and draw air into the syringe that is the same amount (mL) as the dose of NEUPOGEN that your healthcare provider prescribed.

Important: Throw the needle cap into the sharps disposal container.

G

Keep the vial on the flat working surface and insert the needle straight down through the rubber stopper. Do not insert the needle through the rubber stopper more than 1 time.

H

Push the plunger down and inject all the air from the syringe into the vial of NEUPOGEN.

Image

I

Keep the needle in the vial and turn the vial upside down. Make sure that the NEUPOGEN liquid is covering the tip of the needle.

Image

J

Keep the vial upside down and slowly pull back on the plunger to fill the syringe barrel with NEUPOGEN to the correct marking amount (mL) of medicine that matches the dose your healthcare provider prescribed.

K

Keep the needle in the vial and check for air bubbles in the syringe. If there are air bubbles, gently tap the syringe barrel with your finger until the air bubbles rise to the top. Slowly push the plunger up to push the air bubbles out of the syringe.

Image

L

Keep the tip of the needle in the liquid and again pull the plunger back to the number on the syringe barrel that matches your dose. Check again for air bubbles. The air in the syringe will not hurt you, but too large an air bubble can reduce your dose of NEUPOGEN. If there are still air bubbles, repeat the steps above to remove them.

M

Check again to make sure that you have the correct dose in the syringe. It is important that you use the exact dose prescribed by your healthcare provider. Do not remove the needle from the vial. Lay the vial down on its side with the needle still in the vial.

Step 3: Select and Prepare the Injection Site

N

Prepare and clean your injection site.

Image

Image

You can use:

  • Thigh

  • Stomach area (abdomen), except for a2-inch area right around your navel (belly button)

  • Upper outer area of your buttocks (only if someone else is giving you the injection)

  • Outer area of upper arm (only if someone else is giving you the injection)

Clean your injection site with a clean alcohol wipe.

  • Let your skin dry.

*Do not touch this area again before injecting.

  • If you want to use the same injection site, make sure it is not the same spot on the injection site area you used for a previous injection.

*Do not inject into areas where the skin is tender, bruised, red, or hard. Avoid injecting into areas with scars or stretch marks.

Step 4: Subcutaneous (under the skin) injection

O Remove the prepared syringe and needle from the vial.

P Pinch your injection site to create a firm surface.

Image

**Important:**Keep skin pinched while injecting.

Q Hold the pinch. Insert the needle into the skin at a 45 to 90 degree angle.

Image

R Using slow and constant pressure, push the plunger until it reaches the bottom.

Image

When done gently pull the syringe off of your skin.

Step 5: Finish

S Discard (throw away) the used syringe and vial.

Image

  • Put your used syringes, needles, and vials in a FDA-cleared sharps disposal container right away after use.**Do not throw away (dispose of)**needles, syringes and vials in your household trash.

  • If you do not have an FDA-cleared sharps disposal container, you may use a household container that:

    • is made of a heavy-duty plastic,

    • can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,

    • is upright and stable during use,

    • is leak-resistant, and

    • is properly labeled to warn of hazardous waste inside the container.

  • When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used syringes and needles. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at: http://www.fda.gov/safesharpsdisposal.

*Do not reuse the syringe or vial.

*Do not recycle the syringe, vial, or sharps disposal container or throw them into household trash.

**Important:**Always keep the sharps disposal container out of the reach of children.

T Examine the injection site.****

If there is blood, press a cotton ball or gauze pad on your injection site.**Do not** rub the injection site. Apply an adhesive bandage if needed.

This Instructions for Use has been approved by the U.S. Food and Drug Administration.

NEUPOGEN® (filgrastim)****
Manufactured by:
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, California 91320-1799 U.S.A.
U.S. License No. 1080
Revised: 06/2016

1xxxxxx

© 1991-2016 Amgen Inc. All rights reserved.

v1

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.